Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy.
NGS
SARS-CoV-2
immunogenomics
surveillance
variants
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2022
2022
Historique:
received:
03
05
2022
accepted:
21
06
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
In this study, we report on the results of SARS-CoV-2 surveillance performed in an area of Southern Italy for 12 months (from March 2021 to February 2022). To this study, we have sequenced RNA from 609 isolates. We have identified circulating VOCs by Sanger sequencing of the S gene and defined their genotypes by whole-genome NGS sequencing of 157 representative isolates. Our results indicated that B.1 and Alpha were the only circulating lineages in Calabria in March 2021; while Alpha remained the most common variant between April 2021 and May 2021 (90 and 73%, respectively), we observed a concomitant decrease in B.1 cases and appearance of Gamma cases (6 and 21%, respectively); C.36.3 and Delta appeared in June 2021 (6 and 3%, respectively); Delta became dominant in July 2021 while Alpha continued to reduce (46 and 48%, respectively). In August 2021, Delta became the only circulating variant until the end of December 2021. As of January 2022, Omicron emerged and took over Delta (72 and 28%, respectively). No patient carrying Beta, Iota, Mu, or Eta variants was identified in this survey. Among the genomes identified in this study, some were distributed all over Europe (B1_S477N, Alpha_L5F, Delta_T95, Delta_G181V, and Delta_A222V), some were distributed in the majority of Italian regions (B1_S477N, B1_Q675H, Delta_T95I and Delta_A222V), and some were present mainly in Calabria (B1_S477N_T29I, B1_S477N_T29I_E484Q, Alpha_A67S, Alpha_A701S, and Alpha_T724I). Prediction analysis of the effects of mutations on the immune response (i.e., binding to class I MHC and/or recognition of T cells) indicated that T29I in B.1 variant; A701S in Alpha variant; and T19R in Delta variant were predicted to impair binding to class I MHC whereas the mutations A67S identified in Alpha; E484K identified in Gamma; and E156G and ΔF157/R158 identified in Delta were predicted to impair recognition by T cells. In conclusion, we report on the results of SARS-CoV-2 surveillance in Regione Calabria in the period between March 2021 and February 2022, identified variants that were enriched mainly in Calabria, and predicted the effects of identified mutations on host immune response.
Identifiants
pubmed: 35966675
doi: 10.3389/fmicb.2022.934993
pmc: PMC9366435
doi:
Types de publication
Journal Article
Langues
eng
Pagination
934993Informations de copyright
Copyright © 2022 De Marco, Veneziano, Massacci, Pallocca, Marascio, Quirino, Barreca, Giancotti, Gallo, Lamberti, Quaresima, Santamaria, Biamonte, Scicchitano, Trecarichi, Russo, Torella, Quattrone, Torti, Matera, De Filippo, Costanzo and Viglietto.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
CMAJ. 2021 Oct 25;193(42):E1619-E1625
pubmed: 34610919
Front Microbiol. 2021 Jul 15;12:698365
pubmed: 34335530
Signal Transduct Target Ther. 2020 Dec 28;5(1):299
pubmed: 33372174
Cell Death Differ. 2021 Oct;28(10):2840-2842
pubmed: 34389814
J Clin Pharmacol. 2020 Aug;60(8):954-975
pubmed: 32469437
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
PLoS Comput Biol. 2020 Dec 3;16(12):e1008449
pubmed: 33270653
Brief Bioinform. 2021 Mar 22;22(2):1239-1253
pubmed: 33006605
J Thorac Dis. 2020 Aug;12(8):4434-4449
pubmed: 32944357
Microorganisms. 2021 Oct 18;9(10):
pubmed: 34683488
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Emerg Infect Dis. 2021 Jul;27(7):1789-1794
pubmed: 33883059
Curr Microbiol. 2021 Dec 14;79(1):20
pubmed: 34905108
Elife. 2021 Jan 19;10:
pubmed: 33463525
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Elife. 2020 Oct 28;9:
pubmed: 33112236
Nat Microbiol. 2021 Sep;6(9):1188-1198
pubmed: 34400835
Euro Surveill. 2022 Feb;27(5):
pubmed: 35115077
Rev Med Virol. 2021 Nov;31(6):e2231
pubmed: 33724631
J Chem Inf Model. 2022 Jan 24;62(2):412-422
pubmed: 34989238
J Med Virol. 2022 May;94(5):2019-2025
pubmed: 34997962
PeerJ. 2020 Dec 18;8:e10609
pubmed: 33384909
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
Nat Commun. 2022 Mar 4;13(1):1178
pubmed: 35246509
Infect Genet Evol. 2021 Jul;91:104815
pubmed: 33774178
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
J Transl Med. 2020 Dec 30;18(1):494
pubmed: 33380328
Curr Res Struct Biol. 2022;4:41-50
pubmed: 35156058
Mol Biol Evol. 2016 Jun;33(6):1635-8
pubmed: 26921390
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6
pubmed: 33592168
J Mol Biol. 2021 Jul 23;433(15):167058
pubmed: 34023401
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Nat Med. 2021 Apr;27(4):620-621
pubmed: 33558724
J Transl Med. 2020 Sep 15;18(1):352
pubmed: 32933522
J Infect. 2021 Apr;82(4):e8-e10
pubmed: 33472093
Sci Transl Med. 2022 Mar 9;14(635):eabm7853
pubmed: 35040666
PLoS Negl Trop Dis. 2021 Oct 13;15(10):e0009835
pubmed: 34644287
Nature. 2021 Jul;595(7869):707-712
pubmed: 34098568
Biochem Biophys Res Commun. 2022 Jan 29;590:34-41
pubmed: 34968782
Cell Host Microbe. 2021 Mar 10;29(3):477-488.e4
pubmed: 33535027
Cell Rep. 2021 Jun 29;35(13):109292
pubmed: 34166617
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
MedComm (2020). 2021 Dec 16;2(4):838-845
pubmed: 34957469
Elife. 2021 Aug 20;10:
pubmed: 34414884
J Med Chem. 2022 Feb 24;65(4):2820-2826
pubmed: 33834772
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Cell Host Microbe. 2021 May 12;29(5):747-751.e4
pubmed: 33887205
Nat Microbiol. 2020 Apr;5(4):562-569
pubmed: 32094589
Mol Syst Biol. 2022 Feb;18(2):e10673
pubmed: 35156767
Nat Commun. 2021 Aug 9;12(1):4886
pubmed: 34373458
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Sci Rep. 2021 Oct 12;11(1):20274
pubmed: 34642465
Emerg Infect Dis. 2021 Mar;27(3):970-972
pubmed: 33496249
Nature. 2021 Aug;596(7871):276-280
pubmed: 34237773
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Genome Med. 2021 Oct 14;13(1):164
pubmed: 34649620
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
BMC Bioinformatics. 2014 Mar 24;15:82
pubmed: 24661439
J Mol Model. 2021 May 31;27(6):191
pubmed: 34057647
Virus Genes. 2021 Dec;57(6):556-560
pubmed: 34448987
Antiviral Res. 2020 Apr;176:104742
pubmed: 32057769
Emerg Microbes Infect. 2022 Dec;11(1):1-5
pubmed: 34890524
J Mol Cell Biol. 2021 Dec 30;13(10):712-720
pubmed: 34289053
Front Cell Infect Microbiol. 2022 Jan 18;11:781429
pubmed: 35118007
Nat Med. 2021 Apr;27(4):717-726
pubmed: 33664494
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Viruses. 2021 Jul 31;13(8):
pubmed: 34452380
Cell. 2020 Nov 12;183(4):1024-1042.e21
pubmed: 32991844
Science. 2021 Mar 12;371(6534):1139-1142
pubmed: 33536258
Cell. 2021 Apr 29;184(9):2332-2347.e16
pubmed: 33761326
MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):95-99
pubmed: 33476315